API2-MALT1 chimeric transcript-positive gastroduodenal MALT lymphoma with subsequent development of adenocarcinoma as a collision tumour over a clinical course of 7 years [3]

Histopathology

Volumn 51, Issue 1, 2007, Pages 119-122

  Isaka, T ^a   Nakamura, T ^a   Tajika, M ^a   Kawai, H ^a   Imaoka, H ^a   Okamoto, Y ^a   Aoki, M ^a   Inoue, H ^a   Takahashi, K ^a   Mizuno, N ^a   Sawaki, A ^a   Yamao, K ^a   Seto, M ^a   Yokoi, T ^a   Yatabe, Y ^a   Nakamura, S ^b  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 13; CD20 ANTIGEN; CD23 ANTIGEN; CD3 ANTIGEN; CD45RA ANTIGEN; CD5 ANTIGEN; CD79A ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN D1; HYBRID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN; PROTEIN AP12; PROTEIN BCL 2; PROTEIN MALT1; PROTEIN S 100; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG; UREA;

CARCINOGENESIS; DISEASE ASSOCIATION; DISEASE COURSE; GASTROINTESTINAL CARCINOMA; GENE TRANSLOCATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; LETTER; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; UREA BREATH TEST;

EID: 34250898121     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02718.x     Document Type: Letter

References (17)

1. Harris NL, Jaffe ES, Diebold J et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology 2000 36 69 86.
2. Wotherspoon AC, Doglioni C, Diss TC et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa- associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993 342 575 577.
3. Uemura N, Okamoto S, Yamamoto S et al. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 2001 345 784 789.
4. Lucas PC, Yonezumi M, Inohara N et al. Bcl10 and MALT1, independent targets of chromosomal translocation in MALT lymphoma, cooperate in a novel NF-kappaB signaling pathway. J. Biol. Chem. 2001 21 21.
5. Sugiyama T, Asaka M, Nakamura T et al. API2-MALT1 chimeric transcript is a predictive marker for the responsiveness of H. pylori eradication treatment in low-grade gastric MALT lymphoma. Gastroenterology 2001 120 1884 1885.
6. Liu H, Ye H, Ruskone-Fourmestraux A et al. t(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002 122 1286 1294.
7. Motegi M, Yonezumi M, Suzuki H et al. API2-MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous products. Am. J. Pathol. 2000 156 807 812.
8. Nakamura T, Nakamura S, Yonezumi M et al. Helicobacter pylori and the t(11;18)(q21;q21) translocation in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type. Jpn J. Cancer Res. 2000 91 301 309.
9. Nakamura T, Nakamura S, Yokoi T et al. Clinicopathologic comparison between the API2-MALT1 chimeric transcript-positive and -negative gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type. Jpn J. Cancer Res. 2002 93 677 684.
10. Ott G, Katzenberger T, Greiner A et al. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res. 1997 57 3944 3948.
11. Starostik P, Patzner J, Greiner A et al. Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood 2002 99 3 9.
12. Remstein ED, James CD, Kurtin PJ. Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas. Am. J. Pathol. 2000 156 1183 1188.
13. Hosaka S, Akamatsu T, Nakamura S et al. Mucosa-associated lymphoid tissue (MALT) lymphoma of the rectum with chromosomal translocation of the t(11;18)(q21;q21) and an additional aberration of trisomy 3. Am. J. Gastroenterol. 1999 94 : 1951 1954.
14. Nakamura K, Ueyama T, Yao T et al. Pathology and prognosis of gastric carcinoma. Findings in 10,000 patients who underwent primary gastrectomy. Cancer 1992 70 1030 1037.
15. Nakamura S, Aoyagi K, Iwanaga S et al. Synchronous and metachronous primary gastric lymphoma and adenocarcinoma: a clinicopathological study of 12 patients. Cancer 1997 79 1077 1085.
16. Chan AO, Chu KM, Yuen ST et al. Synchronous gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma in association with Helicobacter pylori infection: comparing reported cases between the East and West. Am. J. Gastroenterol. 2001 96 1922 1924.
17. Copie-Bergman C, Locher C, Levy M et al. Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma? Ann. Oncol. 2005 16 1232 1236.